These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 18571404)

  • 1. Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.
    Middleton DS; Andrews M; Glossop P; Gymer G; Hepworth D; Jessiman A; Johnson PS; Mackenny M; Pitcher MJ; Rooker T; Stobie A; Tang K; Morgan P
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4018-21. PubMed ID: 18571404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designing rapid onset selective serotonin re-uptake inhibitors. Part 3: Site-directed metabolism as a strategy to avoid active circulating metabolites: structure-activity relationships of (thioalkyl)phenoxy benzylamines.
    Middleton DS; Andrews M; Glossop P; Gymer G; Hepworth D; Jessiman A; Johnson PS; MacKenny M; Stobie A; Tang K; Morgan P; Jones B
    Bioorg Med Chem Lett; 2008 Oct; 18(19):5303-6. PubMed ID: 18782666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzylamine histamine H(3) antagonists and serotonin reuptake inhibitors.
    Letavic MA; Stocking EM; Barbier AJ; Bonaventure P; Boggs JD; Lord B; Miller KL; Wilson SJ; Carruthers NI
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4799-803. PubMed ID: 17616397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyrrolidino-tetrahydroisoquinolines as potent dual H3 antagonist and serotonin transporter inhibitors.
    Keith JM; Gomez LA; Wolin RL; Barbier AJ; Wilson SJ; Boggs JD; Mazur C; Fraser IC; Lord B; Aluisio L; Lovenberg TW; Carruthers NI
    Bioorg Med Chem Lett; 2007 May; 17(9):2603-7. PubMed ID: 17317177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.
    Vu AT; Cohn ST; Terefenko EA; Moore WJ; Zhang P; Mahaney PE; Trybulski EJ; Goljer I; Dooley R; Bray JA; Johnston GH; Leiter J; Deecher DC
    Bioorg Med Chem Lett; 2009 May; 19(9):2464-7. PubMed ID: 19329313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel naphthyridines are histamine H3 antagonists and serotonin reuptake transporter inhibitors.
    Letavic MA; Keith JM; Ly KS; Barbier AJ; Boggs JD; Wilson SJ; Lord B; Lovenberg TW; Carruthers NI
    Bioorg Med Chem Lett; 2007 May; 17(9):2566-9. PubMed ID: 17307358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-Benzyl-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amines as selective dual serotonin/noradrenaline reuptake inhibitors.
    Fish PV; Fray MJ; Stobie A; Wakenhut F; Whitlock GA
    Bioorg Med Chem Lett; 2007 Apr; 17(7):2022-5. PubMed ID: 17267217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.
    Fray MJ; Bish G; Fish PV; Stobie A; Wakenhut F; Whitlock GA
    Bioorg Med Chem Lett; 2006 Aug; 16(16):4349-53. PubMed ID: 16750363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.
    Jonathan Fray M; Bish G; Brown AD; Fish PV; Stobie A; Wakenhut F; Whitlock GA
    Bioorg Med Chem Lett; 2006 Aug; 16(16):4345-8. PubMed ID: 16750359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel 5-HT(1A/1B/1D) receptors antagonists with potent 5-HT reuptake inhibitory activity.
    Serafinowska HT; Blaney FE; Lovell PJ; Merlo GG; Scott CM; Smith PW; Starr KR; Watson JM
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5581-5. PubMed ID: 18829312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformationally restricted homotryptamines. Part 5: 3-(trans-2-aminomethylcyclopentyl)indoles as potent selective serotonin reuptake inhibitors.
    Denhart DJ; Deskus JA; Ditta JL; Gao Q; Dalton King H; Kozlowski ES; Meng Z; LaPaglia MA; Mattson GK; Molski TF; Taber MT; Lodge NJ; Mattson RJ; Macor JE
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4031-3. PubMed ID: 19560923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.
    Middleton DS; Andrews M; Glossop P; Gymer G; Jessiman A; Johnson PS; Mackenny M; Pitcher MJ; Rooker T; Stobie A; Tang K; Morgan P
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1434-9. PubMed ID: 16314097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors.
    Wakenhut F; Fish PV; Fray MJ; Gurrell I; Mills JE; Stobie A; Whitlock GA
    Bioorg Med Chem Lett; 2008 Aug; 18(15):4308-11. PubMed ID: 18625557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and Synthesis of Arylamidine Derivatives as Serotonin/Norepinephrine Dual Reuptake Inhibitors.
    Wen H; Qin W; Yang G; Guo Y
    Molecules; 2019 Jan; 24(3):. PubMed ID: 30704101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformationally restricted homotryptamines. Part 6: indole-5-cycloalkyl methylamines as selective serotonin reuptake inhibitors.
    Ditta JL; Denhart DJ; Deskus JA; Epperson JR; Meng Z; Gao Q; Mattson GK; Lapaglia MA; Taber MT; Molski TF; Lodge NJ; Mattson RJ; Macor JE
    Bioorg Med Chem Lett; 2013 May; 23(10):2948-50. PubMed ID: 23578689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.
    Fish PV; Deur C; Gan X; Greene K; Hoople D; Mackenny M; Para KS; Reeves K; Ryckmans T; Stiff C; Stobie A; Wakenhut F; Whitlock GA
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2562-6. PubMed ID: 18387300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further studies on conformationally constrained tricyclic tropane analogues and their uptake inhibition at monoamine transporter sites: synthesis of (Z)-9-(substituted arylmethylene)-7-azatricyclo[4.3.1.0(3,7)]decanes as a novel class of serotonin transporter inhibitors.
    Zhang A; Zhou G; Hoepping A; Mukhopadhyaya J; Johnson KM; Zhang M; Kozikowski AP
    J Med Chem; 2002 Apr; 45(9):1930-41. PubMed ID: 11960503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies toward the discovery of the next generation of antidepressants. Part 2: incorporating a 5-HT(1A) antagonist component into a class of serotonin reuptake inhibitors.
    Mewshaw RE; Meagher KL; Zhou P; Zhou D; Shi X; Scerni R; Smith D; Schechter LE; Andree TH
    Bioorg Med Chem Lett; 2002 Feb; 12(3):307-10. PubMed ID: 11814784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformationally restricted homotryptamines. Part 4: Heterocyclic and naphthyl analogs of a potent selective serotonin reuptake inhibitor.
    Dalton King H; Denhart DJ; Deskus JA; Ditta JL; Epperson JR; Higgins MA; Kung JE; Marcin LR; Sloan CP; Mattson GK; Molski TF; Krause RG; Bertekap RL; Lodge NJ; Mattson RJ; Macor JE
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5647-51. PubMed ID: 17766113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and structure-activity relationships of novel selective norepinephrine and dual serotonin/norepinephrine reuptake inhibitors.
    Boot J; Cases M; Clark BP; Findlay J; Gallagher PT; Hayhurst L; Man T; Montalbetti C; Rathmell RE; Rudyk H; Walter MW; Whatton M; Wood V
    Bioorg Med Chem Lett; 2005 Feb; 15(3):699-703. PubMed ID: 15664840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.